The former Hospital de la Santa Creu i Sant Pau in the neighborhood of El Guinardó, Barcelona, Catalonia, Spain, is a complex built between 1901 and 1930. It is one of the most prominent works of the Catalan modernisme architect Lluís Domènech i Montaner. The complex was listed as a Conjunto Histórico in 1978.

During the past decade, Hospital Santa Creu i Sant Pau conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 34 clinical trials were completed, i.e. on average, 38.6% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 24 clinical trials were completed. i.e. 68.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Santa Creu i Sant Pau" #1 sponsor was "Boehringer Ingelheim" with 19 trials, followed by "PETHEMA Foundation" with 7 trials sponsored, "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 6 trials sponsored, "Seagen Inc." with 6 trials sponsored and "Celgene" with 6 trials sponsored. Other sponsors include 124 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Santa Creu i Sant Pau" #1 collaborator was "Hoffmann-La Roche" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Santa Creu i Sant Pau" are "Acute Myeloid Leukemia" (5 trials), "HIV Infections" (5 trials), "Multiple Myeloma" (5 trials), "Coronary Artery Disease" (4 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "Hospital Santa Creu i Sant Pau" in a lesser frequency.

Most popular intervention types in "Hospital Santa Creu i Sant Pau" are "Drug" (119 trials), "Other" (12 trials), "Device" (8 trials), "Procedure" (5 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "placebo" (6 trials), "Nintedanib" (5 trials), "Carboplatin" (4 trials) and "brentuximab vedotin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Santa Creu i Sant Pau" are 160 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Santa Creu i Sant Pau". undefined are not yet recruiting, 22 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 104 completed trials in Hospital Santa Creu i Sant Pau, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Santa Creu i Sant Pau, 10 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 12 trials that are defined as “Not Applicable".